Alnylam CHRO sells $1.27 million in company stock

it.investing.com (Italian)

Alnylam Pharmaceuticals CHRO Melissa McLaughlin sold $1.27 million in company stock. McLaughlin sold a total of 3,902 shares on April 2 and April 6, 2026. The sales were for tax obligations and under a pre-arranged trading plan. The sales occur as Alnylam stock trades near $319.47, with some analyses suggesting it may be overvalued despite strong revenue growth.


With a significance score of 1.1, this news ranks in the top 56% of today's 33069 analyzed articles.

Get summaries of news with significance over 5.5 (usually ~10 stories per week). Read by 10,000+ subscribers:


Alnylam CHRO sells $1.27 million in company stock | News Minimalist